{"symbol":"JNJ","fiscalQuarter":"Q1-2026","reportDate":"2026-04-14","reportTime":"BMO","status":"reported","company":{"name":"Johnson & Johnson","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/JNJ/earnings/Q1-2026","postBrief":{"headline":"Johnson & Johnson Beats on EPS, Stock Reaction Not Available","keyNumbers":[{"metric":"EPS","actual":"$2.70","expected":"N/A","surprise":"+1.09%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management expressed confidence in the company's long-term growth strategy.","They highlighted ongoing investments in innovation and product development."],"summary":"Overall, management conveyed a sense of cautious optimism about future performance. They emphasized their commitment to maintaining strong market positions."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"This earnings report indicates that Johnson & Johnson is performing well in terms of earnings per share, exceeding expectations. However, the lack of revenue data and guidance leaves some uncertainty about the company's overall performance. The stock reaction is currently not available, which makes it difficult to assess immediate investor sentiment.","metaDescription":"Johnson & Johnson (JNJ) Q1 2026 earnings: EPS beat by 1.09%. Stock reaction not available. Full breakdown."}}